Table 1: Patient characteristics and treatment details.

Patient ID Sub-site Gender Age Presenting Symptom History of Smoking Histology Stage of Disease Radiation Dose Concurrent Chemotherapy V1(cc) V2(cc) Mean SpO2
1 Hypo pharynx Male 65 Pain on swallowing (odynophagia) Yes scc T4aN1 *70/35 No 25.3 12.5 98.17
2 Base of Tongue Male 67 Pain on swallowing (odynophagia) Yes scc T4aN2b *70/35 Yes 62 14 98.36
3 Cervix uteri Female 57 Bleeding per vaginum No scc IIIB @50/25+
ISBT 7Gyx3#		 Yes 209.5 92.2 97.36
4 Nasopharynx Female 38 Bleeding from nostrils No undifferentiated T3N2 @50/25+ 24/12 Yes 45.9 0 97.53
5 Hypopharynx Male 44 Pain on swallowing No scc T4aN2b *70/35 Yes 23.7 5.03 98.73
6 Cervix uteri Female 39 Bleeding per vaginum No scc IIIB 50/25+
ISBT:7Gyx3#		 Yes 242 62 97.2
7 Esophagus Male 56 Difficulty in swallowing (Dysphagia) Yes scc T4N0 #50.4/28 Yes 125.5 33.01 99.08
8 Supraglottis Male 77 Hoarsnes of voice Yes scc T3N2c *70/35 No 72 31 97.88
9 Esophagus Male 53 Difficulty in swallowing (Dysphagia) Yes scc T4N0 #50.4/28 Yes 33.8 14 98.68
10 Vallecula Male 65 Pain while swallowing (odynophagia) Yes scc T3N0 *70/35 Yes 20.2 10 98.58

abbreviation: scc=squamous cell carcinoma;;; V1=volume of disease prior to treatment; V2= volume of residual disease post-treatment; *2 Gy per fraction, one fraction per day, over 7 weeks; # 1,8 Gy per fraction, one fraction per day, over 6 weeks; @ 2 Gy per fraction, one fraction per day, over 5 weeks followed by ISBT(Interstitial Brachytherapy) 7 Gy in 3 fractions over 2 weeks;$ cDDP 40 mg /m2 weekly; patients 3 and 5 had past pulmonary tuberculosis, treated and tested sputum-negative before initiation of treatment.